Dr. Anang Shelat is an expert in chemical informatics and assay development, with an expanding portfolio of innovative and collaborative research efforts. His scientific journey began at Harvard, continued at UCSF, and ultimately led to postdoc fellowship and faculty appointment at St. Jude. Dr. Shelat and his team developed invaluable analytical tools for drug screening that have helped shape preclinical therapeutic development, and clinical efforts, across the hematological, brain, and solid tumor landscape. Insightful, energetic, and meticulous, Dr. Shelat is highly regarded across the institution as an extraordinary research partner. He also serves as director of the Lead Discovery Informatics Center in the Department of CBT.